產品詳情
簡單介紹:
MatrixGlaProtein(MGP)(MiddleRegion)Peptide
詳情介紹:
| Blocked Antibody | anti-Matrix Gla Protein (MGP) (Middle Region) antibody (ABIN2784506) |
| Characteristics | This is a synthetic peptide designed for use in combination with anti-MGP antibody (Catalog #: ARP51308_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. |
| Purification | Purified |
| Background |
MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation. Alias Symbols: GIG36, MGLAP, NTI Protein Interaction Partner: BMP2,BMP2 Protein Size: 103 |
| Molecular Weight | 12 kDa |
| Gene ID | 4256 |
| NCBI Accession | NM_000900, NP_000891 |
| UniProt | P08493 |
| Research Area | Signaling, Extracellular Matrix |
| Application Notes | Each Investigator should determine their own optimal working dilution for specific applications. |
| Restrictions | For Research Use only |
| Format | Lyophilized |
| Reconstitution | Add 100?μL of sterile PBS. Final peptide concentration is 1?mg/mL in PBS. |
| Concentration | 1 mg/mL |
| Buffer | Final peptide concentration is 1 mg/mL in PBS. |
| Handling Advice | Avoid repeated freeze-thaw cycles. |
| Storage | -20 °C |
| Storage Comment | For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles. |